Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE The results showed increased SOCS-1 hypermethylation in CRC samples compared to controls. 27133036 2016
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 AlteredExpression disease BEFREE Our results show that SOCS1 mRNA levels in tumours were more often elevated than reduced with respect to matched adjacent normal tissue of CRC specimens (n = 41). 26391193 2015
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 GeneticVariation disease BEFREE The results of our study did not point towards a major role of the SOCS-1 -1478CA>del polymorphism in the pathogenesis of CC in Turkish subjects. 24460337 2013
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE The aim of the present study was to examine the presence of DNA sequences of five human DNA viruses (assessed by PCR): JC polyoma virus (JCV), human adenovirus (AdV), Epstein-Barr virus (EBV), Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) and human papillomavirus (HPV) in a cohort of 186 sporadic colorectal cancers (CRCs) and related these data with the methylation status of six CpG island methylator phenotype (CIMP)-specific genes (MLH1, CACNA1G, NEUROG1, IGF2, SOCS1, RUNX3) and seven cancer-related genes markers (p16, MINT1, MINT2, MINT31, EN1, SCTR and INHBB) assessed by methylation-specific PCR in 186 and 134 CRC cases, respectively. 21625944 2011
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE Utilizing 903 population-based colorectal cancers and real-time PCR (MethyLight), we quantified DNA methylation in WRN and eight other promoters (CACNA1G, CDKN2A, CRABP1, IGF2, MLH1, NEUROG1, RUNX3 and SOCS1) known to be specific for CIMP. 18084250 2008
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 Biomarker disease BEFREE Utilising MethyLight technology, we quantified DNA methylation in MGMT and eight other markers (a CIMP-diagnostic panel; CACNA1G, CDKN2A (p16), CRABP1, IGF2, MLH1, NEUROG1, RUNX3 and SOCS1) in 920 population-based colorectal cancers. 17339237 2007
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE Aberrant methylation of HLTF, SOCS-1, and CDH13 genes is shown in colorectal cancers without lymph node metastasis. 15793636 2005
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE Our findings suggest that inactivation of some tumor suppressor genes through aberrant promoter methylation of CpG islands may play a role in the development of colorectal cancer and methylation inactivation of these genes except p16 and SOCS1 may occur at the precancerous stage. 14719065 2004
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.090 PosttranslationalModification disease BEFREE These findings suggested that SOCS-1 may act as a tumor suppressor in at least some colorectal cancers and that SOCS-1 methylation may be a particular phenomenon related to a nearly onset of colorectal cancer. 15074307 2004